To further examine the relationship between Bid expression and poor prognosis following radiotherapy, patients were stratified according to Bid expression and survival was analysed according to tumour cell radiosensitivity, (SF2, Figure 5); in those patients with low/moderate tumour Bid expression, SF2 retained prognostic significance for disease-specific, recurrence-free and metastasis-free survival. The gene discussed is BID; the disease is neoplasm.